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Isopentenyl diphosphate:dim ethylallyl diphosphate 
isom erase (IPP isom erase) is an enzym e in the isopre- 
noid biosynthetic pathw ay w hich catalyzes the in ter­
conversion o f the prim ary five-carbon hom oallylic and 
ally lic  diphosphate building blocks. We report a sub­
stantia lly  im proved procedure for purification o f this 
enzym e from Sacch arom yces cerevisiae . An amino- 
term inal sequence (35 amino acids) w as obtained from  
a highly purified preparation o f IPP isom erase. Oli­
gonucleotide probes based on the protein sequence  
w ere used to isolate the structural gene encoding IPP  
isom erase from a yeast X library. The cloned gene 
encodes a 33 ,350 -d a lton  polypeptide o f 2 8 8  amino 
acids. A 3 .5-k ilobase E coR l fragm ent containing the 
gene w as subcloned into the yeast shuttle vector  
Y R p l7 . Upon transform ation w ith  plasm ids contain­
ing  the insert, a 5—6 -fold increase in  IPP isom erase  
activ ity  w as seen in transform ed cells relative to 
Y R p l7  controls, confirm ing the identity o f  the cloned  
gene. This is the first reported isolation o f the gene for 
IP P  isom erase.
The isoprenoid biosynthetic pathway is ubiquitous and 
produces a wide variety of small, usually lipophilic molecules 
which fulfill a number of important functions (Spurgeon and 
Porter, 1981). Prominent examples include sterols (structural 
components of eukaryotic membranes, hormones), carotenes 
(photoreceptors in visual and photosynthetic systems), glyc­
eryl ethers (archaebacterial membranes), respiratory coen­
zymes, insect juvenile hormones, cytokinins (plant hor­
mones), and phosphorylated polyprenols (sugar carriers in 
biosynthesis of bacterial cell wall polysaccharides and eukar­
yotic glycoproteins). Isoprenoids are constructed in two dis­
tinct building phases. The first is the stepwise assembly of 
(S)-3-hydroxymethylglutaryl-coenzyme A (CoA)1 from three 
molecules of acetyl-CoA by a Claisen and an aldol condensa-
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tion. The second encompasses a complex set of alkylation 
reactions between nucleophilic acceptors and electrophilic 
allylic isoprenoid diphosphates catalyzed by prenyltransfer- 
ases, a family of enzymes responsible for construction of 
polyisoprenoid chains and attaching these chains to a variety 
of isoprenoid and non-isoprenoid acceptors (Poulter and Rill­
ing, 1981a). Fig. 1 illustrates the early parts of the pathway 
common to all organisms, and the ultimate metabolites com­
monly found in mammals.
Dimethylallyl diphosphate (DMAPP) is the primer for all 
subsequent prenyl transfer reactions. The potent electrophile 
is created from isopentenyl diphosphate (IPP) through a [1.3] 
transposition of hydrogen catalyzed by IPP:DMAPP isomer­
ase (EC 5.3.3.2) (Poulter and Rilling, 1981b) as shown in 
Scheme 1. Although i-somerase activity is ubiquitous, little is 
known about how the enzyme is regulated, no isomerase 
mutants are known for any organism, and significant purifi­
cations of the enzyme have only been reported from three 
sources, porcine liver (Banthorpe et al., 1977; Bruenger et al., 
1986), Claviceps (Bruenger et al., 1986; Muehlbacher and 
Poulter, 1988), and Saccharomyces cerevisiae (Reardon and 
Abeles, 1986). The structure of the enzyme has not been 
characterized. Mechanistic studies indicate that isomerization 
occurs by a protonation-deprotonation sequence involving a 
highly electrophilic carbocationic species (Muehlbacher and 
Poulter, 1988; Reardon and Abeles, 1986). Similar enzyme- 
catalyzed protonations of unactivated carbon-carbon double 
bonds rarely occur in nature.
We now report an improved procedure for purification of 
IPP isomerase which was developed as part of a study of the 
mechanism of action of the enzyme (Muehlbacher and Poul­
ter, 1988; Muehlbacher et al., 1989). The amino-terminal 
sequence of the enzyme was determined and used to design 
oligonucleotide probes for the isolation of clones containing 
the IPP isomerase gene from a yeast genomic DNA library. 
The identified gene encodes a 33,350-dalton protein whose 
NH2-terminal sequence matched that of IPP isomerase. Yeast 
transformants containing multiple extrachromosomal copies 
of the IPP isomerase gene gave a 5-fold increase in IPP 
isomerase activity above controls.
EXPERIMENTAL PROCEDURES
Materials
[ l-14C]Isopentenyl diphosphate (IPP) was purchased from Amer- 












19170 Isolation of the Yeast Gene for IP P  Isomerase
F ig . 1. A n  o u t l in e  o f  th e  b u ild in g  
r e a c t io n s  in  th e  iso p r e n o id  p a th ­
w a y .  The steps through isomerization 
of IPP to DMAPP are common to all 
organisms. The prenyltransfer steps 
(PT) requiring electrophilic allylic di­
phosphates shown are those commonly 
encountered in mammals. The number 
of carbons refers to those derived from 
the isoprene pathway in each metabolite 
or class of metabolites. Processing reac­
tions in sterol metabolism commonly re­
move three isoprenoid carbons from lan- 
osterol (C30).
Ubiquinone (C50)
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Schwartz/Mann. Microcrystalline DE52 ion exchange resin was from 
Whatman, and PBE 94 Polybuffer Exchanger and Polybuffer 74 were 
from Pharmacia LKB Biotechnology Inc. n-Butylsepharose was pre­
pared as reported by Woodside (1987). Fleischmann’s yeast paste was 
purchased from Western Standard Distributing Company, Salt Lake 
City, UT. Radioactivity was measured in Optifluor scintillation media 
(Packard Instrument Company) using a Packard Tricarb model 4530 
liquid scintillation spectrometer.
Strains, Media, and Growth Conditions
The yeast strain used was JGY195 (M A Ta, ode5, gallA102, leu2-
3, Ieu2-ll2, trpl-289, ura3-52; J. Yarger, Amoco Technology Co.), 
Escherichia coli strains DH5a (F~, 08OdiacZAM15, endAl, recAl, 
h xd R ll (rising, supE44, thi-X, A- , gycA96, relAl; Bethesda Research 
Laboratories) and JM101 (A(lac-proAB), supE, th ifF ', fraD36, 
proAB, /acIqZAM15; Yanisch-Perron et al., 1985) were used for routine 
cloning procedures. X-phage were propagated in E. coli strain LE392 
(F~, hsdR514 (ri^mS), supE44, supF58, lacYl or A(facIZY)6, galK2, 
galT22, metB l, trpR55, X- ; Maniatis et al., 1982). Untransformed 
yeast strains were grown at 30 °C in YEPD media (Sherman et al., 
1986). Yeast strains harboring plasmids were grown in SD synthetic 
complete minimal media (Sherman et al., 1986) lacking uracil (ura3 
selection).
General Procedures
Plasmid preparations, transformations, and other standard molec­
ular biology techniques were carried out as described (Maniatis et al., 
1982). Transformations of yeast were performed by the lithium ace­
tate procedure (Sherman et al., 1986).
Ion exchange chromatography, gel exclusion chromatography, and 
affinity chromatography of proteins were conducted at 4 °C. HPLC 
was carried out at 25 °C on a Waters system. Dialysis was performed 
in Spectrapor dialysis bags (25.5 mm, M, cutoff 6000-8000), or in a 
Micro-ProDicon model 115 forced dialysis concentrator using Pro­
Dimem PA-10 dialysis membranes (M r cutoff 10,000). Concentration 
of protein solutions was performed in an Amicon stirred ultrafiltra­
tion cell (50 ml capacity) using a PM-10 filter (M, cutoff 10,000). 
SDS-polyacrylamide gel electrophoresis of proteins was performed 
using the discontinuous buffer system of Laemmli (1970). Gels were 
stained with Coomassie Brilliant Blue R or silver nitrate (Merril et 
al., 1981). Protein was measured by the method of Bradford (Scopes, 
1982) using bovine serum albumin as standard. Isomerase assays were 
performed using the acid lability procedure (Satterwhite, 1985).
Purification of IPP  Isomerase
All enzyme isolation procedures were at 4 °C except HPLC chro­
matographies, which were at 25 °C. Plasticware was used throughout 
the purification. We performed the following steps using cells dis­
rupted either by sonication or with a bead mill. Both procedures 
involved significant heating despite constant immersion in ice and 
frequent breaks to recool the solutions. Yields from sonicated material 
were half that of the bead mill in initial extracts. The enzyme analyzed 
for NH2-terminal sequence was isolated from cells disrupted by the 
sonication procedure.
Bead Mill Procedure—To a 250-ml bead-beater vessel (Biospec 
Products, Bartlesville, OK) was added 4 oz of 0.5-mm beads. The 
container was topped with a yeast suspension containing 1.5 kg of 
baker’s yeast paste suspended in 1.5 liters of 100 mM potassium 
phosphate, pH 7.0,10 mM BME, 1 mM phenylmethylsulfonyl fluoride, 
and cycled for 8 min, 15 s on and 15 s off, using an ice water jacket
for cooling. The disrupted material was held on ice while the proce­
dure was repeated until all of the suspension had been processed. The 
pH of the combined extracts was adjusted to 5.0 with 3.5 M acetic 
acid and stirred for 10 min. The precipitated material was removed 
by centrifugation at 11,000 x  g for 45 min. The recovered supernatant 
was adjusted to pH 7.0 with 1.5 M ammonium hydroxide and frac­
tionated with ammonium sulfate as described below.
Sonication Procedure—Fleischmann’s yeast paste (1.5 kg) was 
suspended in 1.5 liter of extraction buffer as described above and 
divided into 4 X  750 ml batches. The batches were sonicated (Bronson 
SonifierR Cell Disruptor model 350 equipped with a high gain disrup- 
tor %-inch horn), while being cooled in ice water, at a power setting 
of 7 and a duty cycle setting of 70% for 40 min. The pH was adjusted 
to 5.0 with 3.5 M acetic acid, and the suspension was stirred for 10 
min. The precipitated material was removed by centrifugation at
11,000 X  g for 45 min. The pH of the supernatant was adjusted to 7.0 
with 1.5 M ammonium hydroxide.
The total volume of clarified extracts produced by either bead 
milling or sonication was 1700 ml. The pellet obtained by precipita­
tion with ammonium sulfate (45-75% fraction) was dissolved in a 
minimal amount of 100 mM potassium phosphate, 10 mM BME, pH 
7.0, buffer and dialyzed overnight against 4 x 4  liter changes of the 
same buffer.
The solution was loaded onto a 5.0 x  30-cm column of DE52 
cellulose equilibrated with 100 mM potassium phosphate, 10 mM 
BME, pH 7.0. The column was washed with starting buffer (approx­
imately 900 ml) until the UV absorbance of the eluate at 280 nm 
returned to the base line. IPP isomerase was eluted with a linear 
gradient, 3000 ml of 100-500 mM potassium phosphate, 10 mM BME, 
pH 7.0. Fractions of 25 ml were collected. Those containing activity 
(79-89) were pooled, saturated with ammonium sulfate, and centri­
fuged. The pellet was dissolved in a minimal amount of 5 mM 
potassium phosphate, 10 mM BME, pH 7.0, and dialyzed overnight 
against 4 X 2  liter changes of the same buffer.
A 5 X  21-cm n-butyl-Sepharose column was equilibrated with 5 
mM potassium phosphate, 10 mM BME, pH 7.0. Protein from two 
DE52 chromatographies was loaded in starting buffer and eluted with 
a linear gradient (2000 ml) of 5-100 mM potassium phosphate, 10 
mM BME, pH 7.0. Fractions of 17 ml were collected. Those with the 
highest activity (34-50) were pooled and concentrated to a final 
volume of 6 ml in an Amicon-stirred ultrafiltration cell fitted with a 
PM-10 membrane. The concentrated solution was dialyzed against 2 
x  2 liter changes of 10 mM potassium phosphate, 2 mM dithiothreitol, 
pH 7.0.
A 1.5 x  27-cm column of PBE 94 exchanger (Pharmacia LKB 
Biotechnology Inc.) was equilibrated with 25 mM piperazine-HCl, 10 
mM BME, pH 5.5. Enzyme was loaded through an injection loop and 
eluted with 1000 ml of 1:10 diluted Polybuffer 74 (Pharmacia LKB 
Biotechnology Inc.), 10 mM BME, pH 7.0. Fractions of 5 ml were 
collected. Those with the highest activity (20-30) were pooled, satu­
rated with ammonium sulfate, stirred for 60 min, and centrifuged. 
The pellet was dissolved in a minimal amount of 10 mM potassium 
phosphate, 2 mM dithiothreitol, pH 7.0, to a final volume of 3 ml.
A 1.5 X  80-cm column of Sephacryl S-200 was equilibrated with 25 
mM potassium phosphate, 100 mM NaCl, 10 mM BME, pH 7.0. The 
protein was loaded through an injector loop and eluted with the same 
buffer. Fractions of 2 ml were collected, and those with the highest 
activity (19-24) were combined, concentrated, and dialyzed in a 
Micro-ProDicon concentrator against 1 liter of 25 mM potassium 





















A 0.75 x  7.5-cm Protein Pak DEAE-5PW column was equilibrated 
with 10 m M  potassium phosphate, pH 7.0. The protein was loaded 
onto the column through a 5 ml loop injector, and separation of IPP 
isomerase from most remaining contaminants (including a reddish 
brown material) was achieved with the following potassium phosphate 
gradient run at pH 7.0: 0-5 min, 10 m M , pH 7.0; 5-20 min, 10-300 
m M  (linear); 20-50 min, 300 m M  (isocratic). Fractions of 0.35 ml were 
collected, and those with the highest activity (10-15) were pooled, 
concentrated, and dialyzed in a Micro-ProDicon concentrator against 
1 liter of 25 m M  potassium phosphate, 5 m M  dithiothreitol, pH 7.0, 
to give a final volume of 0.7 ml. Samples of this preparation were 
stored at —70 °C for periods of longer than 3 weeks without significant 
loss of activity. SDS-gel electrophoresis of this preparation revealed 
a major protein band at approximately 39,000 daltons judged to be 
greater than 95% pure.
Cloning of the IPP  Isomerase Gene
A sample of the purified protein was submitted to the University 
of Illinois Biotechnology Center for NH2-terminal Edman degrada­
tion. This analysis gave a 35-amino acid sequence in which cycle 9 
was indeterminate, cycle 22 was either lie or Gin, and cycles 32-35 
were less certain. This sequence was used to construct the two single­
stranded DNA probes shown in Fig. 2. The oligonucleotide probes 
were 5' end-labeled with [7 -32P]ATP and used to screen a yeast 
genomic library constructed in the X vector MG14 by cloning partial 
Sau3AI yeast DNA fragments into BamHI vector arms lacking EcoRI 
and HindiII sites (Olson et al., 1986).
DNA from 10,000 plaques of this library was transferred to each 
of four sets of nitrocellulose filters, and each probe described above 
was hybridized to two sets of filters under low stringency conditions 
(0.9 M NaCl, 90 mM sodium citrate, pH 7.4, 5 x  Denhardt’s solution,
0.1% SDS, 100 Mg/ml salmon sperm DNA, and 100 jig/ml wheat germ 
tRNA at 40 °C for 10 h). Ten plaques were found which hybridized 
to both probes. After plaque purification and rescreening, Southern 
analysis of the phage DNAs revealed that most contained a 3.5-kb 
EcoRI fragment that hybridized to both probes. Other phage DNAs 
produced a hybridizing EcoRI fragment corresponding to one arm of 
the X vector. The 3.5-kb .EcoRI fragment was ligated into the vector 
pBluescript SK(+) (Stratagene) in both orientations. The resulting 
phagemids were designated pARCl33A and pARCl33B.
Sequencing Methods
DNA sequence analysis of the IPP isomerase gene was performed 
by the dideoxy-chain termination method of Sanger et al. (1977) using 
the Sequenase® kit (U.S. Biochemicals). Initial sequencing reactions 
were carried out using a subset of nucleotides present in probe 1 as a 
sequencing primer. Computer-assisted analysis of sequence data was 
performed using the PC Gene programming package (Intelligenetics 
Inc., Mountainview, CA). Strain JM101 was used as the host for 
phagemid (pBluescript SK(+))-based plasmids. Helper phage R408 
(Stratagene) was used as directed by the supplier to produce single­
stranded phagemid DNA.
Expression of the IP P  Isomerase Gene
A 3.5-kb EcoRI fragment from pARCl33A was subcloned into the 
yeast shuttle vector YRpl7. The resulting plasmids with the insert 
in both directions, pMA150A and pMA150B, were used to transform 
yeast strain JGY195 to uracil prototrophy. The transformants were 
grown as described above. Samples were harvested by centrifugation 
and assayed for IPP isomerase activity.
Incubation of IPP  Isomerase with Endo H
Incubations of native isomerase with endo H were conducted 
essentially as described by Julius et al. (1984). Reactions contained 
50 ng of IPP isomerase, 10 milliunits of endo H in 0.3 M sodium 
citrate buffer, pH 5.5, and were incubated at 37 °C for 20 h prior to 
analysis by SDS-PAGE. Samples of denatured IPP isomerase were 
prepared for digestion with endo H as described by Trimble and 
Maley (1977).
Concanavalin A-binding Assays
Lectin-binding experiments with IPP isomerase were carried out 
using [14C-met%/]concanavalin A (specific activity 13.9 iiCi mg"1) 
and the gel overlay procedure of Chu et al. (1981). The gel overlay 
solution contained 0.02 mg ml-1 of the labeled concanavalin A, 5 mg 
ml-1 of hemoglobin in 50 m M  Tris-HCl, 600 m M  sodium chloride, 0.1
m M  calcium chloride, 0.1 m M  magnesium chloride, pH 7.5. Samples 
of IPP isomerase (10 ng) and deoxyribonuclease A (10 ng) were 
subjected to SDS-PAGE, the gel was stained with Coomassie Blue, 
equilibrated with Tris-HCl buffer, overlayed with the above solution, 
and allowed to stand at room temperature for 18 h. Unbound lectin 
was removed by several washes with Tris-HCl buffer, and the gel was 
dried onto Whatman No. 3MM paper prior to autoradiography using 
Kodak X-omat film.
RESULTS
Purification of IPP Isomerase—As part of a study of the 
mechanism of action of IPP isomerase, we developed an 
improved procedure for purification of the enzyme from S. 
cerevisiae based on a combination of previous reports (Bruen- 
ger et al., 1986; Reardon and Abeles, 1986; Muehlbacher and 
Poulter, 1988). Our protocol, summarized in Table I, yielded 
material which gave a single band (>95%) on SDS gels at
39.000 daltons. This molecular weight is consistent with the 
value of 40,000 found by Reardon and Abeles (1986). However, 
the specific activity of our preparation was 4.6-fold greater 
than they reported.
Cloning of the IPP Isomerase Gene—Edman degradation of 
the purified protein afforded a 35-amino acid sequence in 
which one position was not assigned and another was ambig­
uous. The sequence, shown in Fig. 2, was used to construct 
DNA probes for screening a yeast genomic DNA library for 
the IPP isomerase gene.
Two probes were constructed from the NH2-terminal pro­
tein sequence (see Fig. 2). Probe 1 was 17 nucleotides in 
length and degenerate for all possible amino acid codons. 
Probe 2 was a 56-mer based on codon usage for highly ex­
pressed yeast genes (Bennetzen and Hall, 1982). We screened
10.000 plaques of a yeast genomic library for the presence of 
sequences complimentary to these non-overlapping probes. 
After plaque purification and rescreening, seven purified 
phages were obtained. Five contained a 3.5-kb .EcoRI fragment 
which bound both probes (Fig. 3). EcoRI digestion of the other 
two phage DNAs resulted in the hybridizing phage DNA 
region being retained on one arm of the X vector. The 3.5-kb 
.EcoRI fragment was ligated into the phagemid pBluescript 
SK(+) in both orientations. These constructions were desig­
nated pARC133A and pARC133B. Southern blot analysis of 
these clones revealed both probes hybridized between the 
Kpnl and Pvull sites.
Nucleotide Sequence of IPP Isomerase Gene—Initially, sin­
gle-stranded DNA from each of the phagemids pARCl33A 
and pARCl33B was used as template for sequencing reactions 
using a subset of the oligonucleotides present in probe 1 as 
primers. This allowed us to sequence the DNA in the vicinity 
of the gene corresponding to the NH2 terminus of the protein 
and to establish the direction of the gene on the DNA frag­
ment. Sequenced regions were propagated using synthetic 
primers that hybridized to the ends of previously sequenced
T a b l e  I






fxmol min~' mg nmol mg-1 % -fold
pH 5.0 supernatant 130 30,900 0.004 (100) 1
45-75% (NH4)2S 0 4 115 21,175 0.005 88 1.3
pellet
DE52 cellulose 108 772 0.14 83 33
re-Buty 1 - Sepharose 67 86 0.78 52 186
Chromatofocusing 36 11 3.2 28 762
Sephacryl S-200 33 3.6 9.2 25 2,180
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F ig. 2. Probes used for gene isolation and comparison o f protein and DNA sequences for yeast IPP  
isom erase. The top continuous line is the 5' sequence of the IPP isomerase gene. Immediately below the DNA 
sequence is the derived protein sequence. The bottom line is the actual protein sequence determined by Edman 
degradation. Cycle 9 was unassignable, and cycle 22 was ambiguous as either glutamine or isoleucine. Above the 
DNA sequence are the probes used to screen for the gene. Probe 1 is a mixture of all possible 17-mers that could 
code for amino acids 3-8 without the last base of the proline 8 codon. Probe 2 is a single 56-mer oligonucleotide 













I_______ S X b-LI__ PARC133A
F ig. 3. Location o f IPP  isom erase gene on insert o f  pARC133A. The 3.5-kb EcoRl insert of pARC133A 
is shown. The thick arrow shows IPP isomerase gene location and direction. Arrows below show the strategy used 
for sequencing. pARC133A and pARC133B were used as template for synthetic primers based on probe 1. The 
DNA sequence in the vicinity of the NH2 terminus of the protein and the direction of the gene on the DNA 
fragment were established. Sequenced regions were propagated using synthetic 18-mers designed to hybridize to 
the ends of previously sequenced DNA. Overlapping sequences from left to right were obtained with pARC133A 
and from right to left with pARC133B. Abbreviations are as follows: E, KcoRI; K, Kpnl; P, Pvull; S, Sail; Xb, 
Xbal; Xh, Xhol.
DNA. The strategy used in sequencing the entire IPP isomer­
ase gene and the restriction map for the region are given in 
Fig. 3. Both strands were sequenced with overlaps to resolve 
any ambiguities. The nucleotide sequence of the IPP isomer­
ase gene and flanking DNA is shown in Fig. 4. The structural 
gene is 864 base pairs and encodes a 33,500-dalton protein.
Fig. 2 shows the DNA sequence of the region complemen­
tary to probes 1 and 2. Immediately below the DNA sequence 
is the amino acid sequence of IPP isomerase derived from the 
DNA sequence, and on the bottom line is the NH2-terminal 
protein sequence determined by Edman degradation. Com­
parison of the two protein sequences indicates that the native 
enzyme lacks its initiating methionine. The unassigned amino 
acid at cycle 9 corresponds to a histidine residue, and the 
ambiguous signal at cycle 22 in the degradation is glutamine. 
The perfect match between NH2-terminal amino acid se­
quence of the enzyme and the protein sequence derived from 
the DNA sequence was our first confirmation that our clone 
contained the IPP isomerase gene. The pi for IPP isomerase 
of 4.6 predicted from the protein sequence is in good agree­
ment with the value of 4.5 measured by isoelectric focusing 
(Robertson et al., 1987).
The level of transcription and expression of the IPP i-
somerase gene can be approximated from the codon bias 
inherent in the coding sequence. The codon bias index defined 
by Bennetzen and Hall (1982) measures the extent to which 
a preferred set of 25 yeast codons of the possible 61 triplets 
are utilized. The codon bias index has been found to correlate 
with the protein and mRNA abundance. For IPP isomerase, 
the codon bias index (see Table III) is low (0.24) and is in the 
range typically seen for biosynthetic enzymes. Based on the 
specific activity of purified isomerase, we estimate the enzyme 
constitutes approximately 0.03% of the soluble protein.
Elevated Expression of the IPP Isomerase Gene—Convinc­
ing evidence for the existence of a gene for IPP isomerase in 
pARCl33A was obtained by first subcloning the 3.5-kb ficoRI 
fragment into YRpl7 in both orientations, designated 
pMA150A and pMA150B. Yeast strain JGY195 and trans­
formants containing YRpl7, pMA150A, and pMA150B were 
then assayed for IPP isomerase activity at various times 
during their growth cycles. The results are summarized in 
Table II.
In the transformed strains, the specific activity of IPP 
isomerase reached a maximum in mid-log phase and then 
decreased by 2-3-fold as cells entered stationary phase. A 














































































Fig. 4. N ucleotide and presum ptive amino acid sequence of 
the IPP  isom erase gene. Potential TATA and termination signals 
are underlined. A large poly(dA-dT) region at the 5' end of the gene 
is also underlined.
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T a b l e  II
Inhibition of IPP  isomerase by 3-(fluoromethyl)-3-buten-l-yl 
disphosphate (FIPP) and 3,4-epoxy-l-butenyl diphosphate (EBPP)
Strain
Specific activity"




JGY195 4 0.2 (95) 0.3 (93)
JGY195/YRpl7 8 0.2 (98) 1.0 (88)
JGY195/pMA150A 47 5.9 (87) 2.5 (95)
JGY195/pMA150B 43 4.3 (90) 1.5 (97)
IPP isomerase1’ 122 7.9 (94) 13.4 (89)
PPO' ^  P P 0 '
FIPP EBPP
S c h e m e  2
T a b l e  III
Codon usage in the IPP  isomerase structural gene 
AA, amino acid.
AA Codon No. AA Codon No. AA Codon No. AA Codon No.
Phe TTT 9 Ser TCT 5 Tyr TAT 1 Cys TGT 4
TTC 5 TCC 1 TAC 5 TGC 3
Leu TTA 12 TCA 2 TAA 1 TGA 0
TTG 5 TCG 0 TAG 0 Trp TGG 7
Leu CTT 3 Pro CCT 5 His CAT 9 Arg CGT 1
CTC 0 CCC 1 CAC 1 CGC 0
CTA 6 CCA 8 Gin CAA 10 CGA 1
CTG 0 CCG 0 CAG 0 CGG 0
He ATT 16 Thr ACT 8 Asn AAT 13 Ser AGT 4
ATC 3 ACC 2 AAC 9 AGC 2
ATA 1 ACA 4 Lys AAA 7 Arg AGA 6
Met ATG 7 ACG 2 AAG 12 AGG 2
Val GTT 4 Ala GCT 4 Asp GAT 11 Gly GGT 11
GTC 3 GCC 4 GAC 10 GGC 1
GTA 1 GCA 3 Glu GAA 2 GGA 1
GTG 3 GCG 2 GAG 6 GGG 0
° Determined for cell-free extracts from cultures after 18 h of 
incubation. Transformed strains were at mid-log phase. Untrans­
formed JGY195 was in late-log to early stationary phase.
6 Preincubated for 20 min at 37 °C before addition of IPP.
' Preincubated with 10 nM FIPP for 20 min at 37 °C before addition 
of IPP.
d Preincubated with 100 uM EBPP for 20 min at 37 °C before 
addition of IPP.
f P a r tia lly  p u rified  from  S. cerevisiae.
proximately 15 h) revealed that transformants containing the 
plasmids pMA150A or pMA150B were 5-6-fold higher than 
in the transformant containing YRpl7. The nearly equal 
levels of IPP isomerase activity in JGY195/pMA150A and 
JGY195/pMA150B indicate that expression is independent 
of orientation. This is an expected result since the 3.5-kb 
EcoRI fragment contains ample regions flanking the promotor 
and terminator elements of the structural gene.
Specific active site-directed irreversible inhibitors of IPP 
isomerase were used to establish that the elevated specific 
activities measured in crude extracts could be attributed di­
rectly to the enzyme. Cell-free extracts of a late-log culture of 
JGY195 and mid-log cultures of JGY195/YRpl7, JGY195/ 
pMA150A, and JGY195/pMAl50B were preincubated with 3- 
(fluoromethyl)-3-buten-l-yl diphosphate or 3,4-epoxy-l-bu­
tenyl diphosphate. These compounds are known to act as 
potent, specific inhibitors of IPP isomerase (Muehlbacher 
and Poulter, 1988; Muehlbacher et al., 1989) (Scheme 2). The 
results of these experiments are summarized in Table III. In 
each case, preincubation with 3,4-epoxy-l-butenyl diphos­
phate or 3-(fluoromethyl)-3-buten-l-yl diphosphate drasti­
cally lowered the specific activity of IPP isomerase. The 
percentage of inhibition was 87-98% for all strains.
Tests for Post-translational Modification—The discrepancy 
between the molecular masses of 33,350 daltons deduced from 
the gene sequence of IPP isomerase and 39,000-40,000 daltons 
determined by SDS-PAGE suggest that the protein is modi­
fied post-translationally, perhaps by glycosylation. The amino 
acid sequence contains potential glycosylation sites at Asn-5, 
Asn-22, and Asn-221. Since the amino-terminal Edman deg­
radation spanned positions 5 and 22, only Asn-221 is a likely 
candidate.
Digestion of IPP isomerase with endo H did not change the 
apparent molecular weight of the polypeptide as deduced by 
comparison with an untreated control on SDS-PAGE under 
conditions where we easily detected a loss of approximately 
2000 daltons from deoxyribonuclease A when treated under 
similar conditions (Tarentino et al., 1974). In addition, no 



















denatured with SDS prior to endo H treatment (Chu et al., 
1981).
Binding experiments between IPP isomerase and concan­
avalin A also gave negative results. Samples of IPP isomerase 
and deoxyribonuclease A were subjected to SDS-PAGE. The 
gel was treated with 14C-methylated concanavalin A, and 
nonspecifically bound lectin was removed by repeated wash­
ing. Autoradiography showed that uC-labeled concanavalin A 
only bound to deoxyribonuclease A.
DISCUSSION
By combining features of several purifications (Bruenger et 
al., 1986; Abeles and Reardon, 1986; Muehlbacher and Poul­
ter, 1988), we obtained a preparation of IPP isomerase from
S. cerevisiae with a 4-5-fold higher specific activity than 
previously reported (Reardon and Abeles, 1986). The IPP 
isomerase gene was then isolated from a X library of yeast 
genomic DNA using oligonucleotide probes whose sequences 
were based on the NH2-terminal sequence of the enzyme. A
3.5-kb EcoRI fragment was obtained that encoded a protein 
of 288 amino acids with a molecular mass of 33,350 daltons. 
The identity of the gene, which we have designated bot 2 
(biosynthesis of terpenes), was established by subcloning the
3.5-kb EcoRI fragment into a yeast shuttle vector which 
produced enhanced levels of IPP isomerase activity in yeast 
transformants.
There is a significant discrepancy between the molecular 
mass of IPP isomerase of 33,350 daltons deduced from the 
gene sequence and the values of 39,000-40,000 daltons deter­
mined by SDS-PAGE of the purified enzyme by us and by 
Reardon and Abeles (1986). We initially suspected that IPP 
isomerase might be glycosylated, and inspection of the amino 
acid sequence suggested potential glycosylation sites at aspar­
agines 5, 22, and 221. However, Edman degradation of the 
amino terminus ruled out glycosylation at Asn-5 and Asn-22. 
Attempts to detect glycosyl units at other sites were unsuc­
cessful. The mobility of IPP isomerase upon SDS-PAGE did 
not change after treatment with endo H. This enzyme hydro­
lyzes glycoproteins at the di-iV-acetylchitobiosyl core common 
to most iV-linked glycoproteins (Tarentino and Maley, 1974; 
Tarentino et al., 1974) with a resulting decrease in molecular 
weight of the polypeptide. Since the susceptibility to endo H 
hydrolysis can vary, we also attempted endo H hydrolysis of 
denatured IPP isomerase (Chu et al., 1981) without success. 
In addition, treatment of the enzyme with radiolabeled con­
canavalin A did not reveal detectable levels of binding between 
IPP isomerase and the lectin, suggesting the absence of a- 
glucoside or a-mannoside linkages (Osawa and Tsuji, 1987). 
The absence of positive indications upon treatment with endo 
H or concanavalin A and the fact that IPP isomerase is a 
cytosolic enzyme suggest that the protein is not glycosylated. 
At this point, the discrepancy between molecular weights 
obtained from the gene sequence and SDS-PAGE of the 
enzyme remains unexplained.
Similar absolute levels of expression were observed in 
JGY195/pMA150A and JGY195/pMA150B. In addition, sim­
ilar patterns of variation of enzyme activity during cell growth 
were observed with both clones. This suggests, as expected 
from the large 5 '-flanking region present, that IPP isomerase 
expression is being controlled by elements flanking the gene 
and not by vector sequences. No consensus TATA box se­
quence (TATAAA) is found upstream of the IPP isomerase 
coding region. A sequence differing by one base from the 
consensus is located 220 base pairs upstream from the initial 
ATG codon and is underlined in Fig. 4. Another feature of 
the upstream sequence is the long stretch of poly(dA dT),
also underlined. Stretches of poly(dA • dT) serve as upstream 
promotor elements for other yeast genes (Struhl, 1985). A 
possible transcription termination sequence (Zaret and Sher­
man, 1982) is also underlined in Fig. 4.
In actively growing cultures of JGY195 transformed with 
pMA150A and pMA150B, the specific activity of IPP isomer­
ase peaked during mid-log phase and then declined by 2-2.5- 
fold as the cultures moved into stationary phase. These results 
are in contrast to levels for the next enzyme in the pathway, 
farnesyl diphosphate synthetase, where the specific activity 
of the enzyme remains constant in controls and transformants 
containing multiple copies of the farnesyl diphosphate syn­
thetase gene (Anderson et al., 1989). DMAPP is the ultimate 
source of allylic substrates needed to prime the prenyltrans- 
ferases for chain elongation by condensation with IPP. Thus, 
the relative demand for DMAPP is higher during periods of 
maximal sterol biosynthesis, which utilizes farnesyl diphos­
phate without further chain elongation, than during biosyn­
thesis of higher prenyl diphosphates needed for production of 
dolichols and ubiquinones where additional IPP is required. 
If differential needs exist for isoprenoids of different chain 
lengths, control of the activity of IPP isomerase might provide 
a mechanism for regulating the relative levels of IPP and 
DMAPP to match metabolic requirements.
IPP isomerase catalyzes an essential activation step in 
isoprenoid metabolism in the conversion of IPP to DMAPP 
by enhancing the electrophilicity of the isoprene unit by at 
least a billion-fold. There are no known IPP isomerase mu­
tants for any organism, and until recently (Bruenger et al., 
1986; Reardon and Abeles, 1986; Dogbo and Camara, 1987; 
Muehlbacher and Poulter, 1988), no reliable purifications of 
the enzyme.2
The reaction catalyzed by IPP isomerase is a simple [1.3] 
hydrogen migration. During the isomerization of IPP to 
DMAPP, the added proton is ultimately derived from water, 
presumably by exchange with an enzymic acid, and the re­
leased proton is lost to water. The reaction is antarafacial 
(Clifford et al., 1971). Thus, two bases, one in the conjugate 
acid form, are required for catalysis. Studies with alternate 
substrates and transition state analogues (Poulter and Muehl­
bacher, 1988; Abeles and Reardon, 1986) established that the 
mechanism for isomerization is a protonation-deprotonation 
reaction via a tertiary carbocation. Enzymatic protonations 
of unactivated olefins are rarely encountered in nature. The 
only prominent examples are IPP isomerase, A8-A7 choles­
terol isomerase (Wilton et al., 1969), and enzymes catalyzing 
proton-initiated cyclizations of isoprenoids (Goodwin, 1981). 
There are no active site structures for any of the members in 
this group and how catalysis is achieved is a mystery. We 
recently discovered a family of suicide substrates and highly 
specific active site-directed irreversible inhibitors for isomer­
ase (Muehlbacher and Poulter, 1988; Muehlbacher et al., 
1989). Although the site of covalent attachment is presently 
unknown, knowledge of the complete amino acid sequence of 
isomerase will facilitate identification of the location of resi­
dues in the catalytic site.
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2 Attempts in our laboratory (C. D. P.) and by Rilling (private
communication) to purify porcine liver IPP isomerase by the Ban-
















Addendum—We have succeeded in expressing the gene for yeast 
IPP isomerase in E. coli. The purified, active enzyme behaved iden­
tically to that obtained from yeast upon SDS-gel electrophoresis. We 
conclude that the difference in molecular weights predicted from the 
gene sequence and from SDS-gels is not due to glycosylation.
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